[Federal Register Volume 66, Number 78 (Monday, April 23, 2001)]
[Notices]
[Pages 20485-20486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9954]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-336]


Northeast Nuclear Energy Company, et al. Millstone Nuclear Power 
Station, Unit No. 2; Notice of Consideration of Issuance of Amendment 
to Facility Operating License and Opportunity for a Hearing

    The U.S. Nuclear Regulatory Commission (the Commission) is 
considering issuance of an amendment to Facility Operating License No. 
DPR-65, issued to Northeast Nuclear Energy Company, et al. (the 
licensee), for operation of the Millstone Nuclear Power Station, Unit 
No. 2 (MP2), located in New London County, Connecticut.
    The proposed amendment would revise the MP2 Final Safety Analysis 
Report (FSAR), Chapter 14, description of the Steam Generator Tube 
Rupture (SGTR) event and its associated radiological dose consequences. 
The changes are not the result of hardware changes to the plant or 
changes in operating practices. Rather, the changes are the result of 
incorporating a postulated loss of offsite power into the event 
analyses as well as revised assumptions and analysis methodology. The 
proposed FSAR changes show that the postulated dose consequences for 
the updated SGTR analysis are higher than the dose consequences for the 
previous analysis.
    Specifically, the proposed changes in the assumptions associated 
with the SGTR analyses will increase the dose consequences for two 
hypothetical cases: Case 1 involves a spike in the reactor coolant 
iodine activity level as a result of the SGTR accident; Case 2 involves 
a pre-accident spike in the iodine activity level. For Case 1, the 
revised calculations result in the following changes to the postulated 
accident doses for the Exclusion Area Boundary (EAB), and Low 
Population Zone (LPZ): EAB thyroid dose increases from .160 REM to 15.4 
REM; EAB whole body dose increases from .146 REM to 2.2 REM; LPZ 
thyroid dose increases from .017 REM to 2.1 REM; and, LPZ whole body 
dose increases from .045 REM to .3 REM. For Case 2, the postulated 
doses would change as follows: EAB thyroid dose increases from .813 REM 
to 27.8 REM; EAB whole body dose increases from .146 REM to .8 REM; LPZ 
thyroid dose increases from .085 REM to 3.7 REM; and LPZ whole body 
dose increases from .045 REM to .1 REM.
    Before issuance of the proposed license amendment, the Commission 
will have made findings required by the Atomic Energy Act of 1954, as 
amended (the Act) and the Commission's regulations.
    By May 21, 2001, the licensee may file a request for a hearing with 
respect to issuance of the amendment to the subject facility operating 
license and any person whose interest may be affected by this 
proceeding and who wishes to participate as a party in the proceeding 
must file a written request for a hearing and a petition for leave to 
intervene. Requests for a hearing and a petition for leave to intervene 
shall be filed in accordance with the Commission's ``Rules of Practice 
for Domestic Licensing Proceedings'' in 10 CFR part 2. Interested 
persons should consult a current copy of 10 CFR 2.714 which is 
available at the Commission's Public Document Room, located at One 
White Flint North, 11555 Rockville Pike (first floor), Rockville, 
Maryland and accessible electronically through the ADAMS Public 
Electronic Reading Room link at the NRC Web site (http://www.nrc.gov). 
If a request for a hearing or petition for leave to intervene is filed 
by the above date, the Commission or an Atomic Safety and Licensing 
Board, designated by the Commission or by the Chairman of the Atomic 
Safety and Licensing Board Panel, will rule on the request and/or 
petition; and the Secretary or the designated Atomic Safety and 
Licensing Board will issue a notice of hearing or an appropriate order.
    As required by 10 CFR 2.714, a petition for leave to intervene 
shall set forth with particularity the interest of the petitioner in 
the proceeding, and how that interest may be affected by the results of 
the proceeding. The petition should specifically explain the reasons 
why intervention should be permitted with particular reference to the 
following factors: (1) The nature of the petitioner's right under the 
Act to be made a party to the proceeding; (2) the nature and extent of 
the petitioner's property, financial, or other interest in the 
proceeding; and (3) the possible effect of any order which may be 
entered in the proceeding on the petitioner's interest. The petition 
should also identify the specific aspect(s) of the subject matter of 
the proceeding as to which petitioner wishes to intervene. Any person 
who has filed a petition for leave to intervene or who has been 
admitted as a party may amend the petition without requesting leave of 
the Board up to 15 days prior to the first prehearing conference 
scheduled in the proceeding, but such an amended petition must satisfy 
the specificity requirements described above.

[[Page 20486]]

    Not later than 15 days prior to the first prehearing conference 
scheduled in the proceeding, a petitioner shall file a supplement to 
the petition to intervene which must include a list of the contentions 
which are sought to be litigated in the matter. Each contention must 
consist of a specific statement of the issue of law or fact to be 
raised or controverted. In addition, the petitioner shall provide a 
brief explanation of the bases of the contention and a concise 
statement of the alleged facts or expert opinion which support the 
contention and on which the petitioner intends to rely in proving the 
contention at the hearing. The petitioner must also provide references 
to those specific sources and documents of which the petitioner is 
aware and on which the petitioner intends to rely to establish those 
facts or expert opinion. Petitioner must provide sufficient information 
to show that a genuine dispute exists with the applicant on a material 
issue of law or fact. Contentions shall be limited to matters within 
the scope of the amendment under consideration. The contention must be 
one which, if proven, would entitle the petitioner to relief. A 
petitioner who fails to file such a supplement which satisfies these 
requirements with respect to at least one contention will not be 
permitted to participate as a party.
    Those permitted to intervene become parties to the proceeding, 
subject to any limitations in the order granting leave to intervene, 
and have the opportunity to participate fully in the conduct of the 
hearing, including the opportunity to present evidence and cross-
examine witnesses.
    A request for a hearing or a petition for leave to intervene must 
be filed with the Secretary of the Commission, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555-0001, Attention: Rulemakings and 
Adjudications Staff, or may be delivered to the Commission's Public 
Document Room, located at One White Flint North, 11555 Rockville Pike 
(first floor), Rockville, Maryland, by the above date. A copy of the 
petition should also be sent to the Office of the General Counsel, U.S. 
Nuclear Regulatory Commission, Washington, DC 20555-0001, and to 
Lillian M. Cuoco, Esq., Senior Nuclear Counsel, Northeast Utilities 
Service Company, P.O. Box 270, Hartford, Connecticut, attorney for the 
licensee.
    Nontimely filings of petitions for leave to intervene, amended 
petitions, supplemental petitions and/or requests for hearing will not 
be entertained absent a determination by the Commission, the presiding 
officer or the presiding Atomic Safety and Licensing Board that the 
petition and/or request should be granted based upon a balancing of the 
factors specified in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d).
    If a request for a hearing is received, the Commission's staff may 
issue the amendment after it completes its technical review and prior 
to the completion of any required hearing if it publishes a further 
notice for public comment of its proposed finding of no significant 
hazards consideration in accordance with 10 CFR 50.91 and 50.92.
    For further details with respect to this action, see the 
application for amendment dated December 21, 2000, which is available 
for public inspection at the Commission's Public Document Room, located 
at One White Flint North, 11555 Rockville Pike (first floor), 
Rockville, Maryland, and accessible electronically through the ADAMS 
Public Electronic Reading Room link at the NRC Web site (http://www.nrc.gov).

    Dated at Rockville, Maryland, this 17th day of April 2001.

    For the Nuclear Regulatory Commission.

Daniel S. Collins,
Project Manager, Section 2, Project Directorate I, Division of 
Licensing Project Management, Office of Nuclear Reactor Regulation.
[FR Doc. 01-9954 Filed 4-20-01; 8:45 am]
BILLING CODE 7590-01-P